![Aaron Goodman: This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors](https://oncodaily.com/pub/uploads/2024/04/IMG_2271-1280x638.jpeg)
Photo taken from aacrjournals.org
Apr 26, 2024, 06:18
Aaron Goodman: This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors
Aaron Goodman shared on X:
“This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors. Useful clinical stuff like time to onset and more.”
Additional information.
Source: Aaron Goodman/X
Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2024, 18:11